Royal Caribbean 주식 가격. R1CL34 - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
브라질
BOV
Royal Caribbean Group (R1CL34) 시세

Royal Caribbean Group (R1CL34)

738.75

-1.25

(-0.17%)

마감 18 12월 5:55AM

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

가격

738.75

매수가

699.81

매도가

0.00

거래량

117

737.25 일간 변동폭 740.25

281.88 52주 범위 897.81

market_cap

전일 종가

740.00

개장가

740.00

최근 거래 시간

마지막 거래 시간

재정 규모

R$ 86,517

VWAP

739.459

평균 볼륨(3m)

92

발행 주식

256,650,000

배당수익률

0.90%

주가수익률

36.61

주당순이익(EPS)

6.61

매출

13.9B

순이익

1.7B

섹터

Deep Sea Pass Trans,ex Ferry

산업

Deep Sea Pass Trans,ex Ferry

웹사이트

www.royalcaribbeangroup.com

본부

Miami, Florida, USA

설립됨

-

Royal Caribbean Group is listed in the Deep Sea Pass Trans,ex Ferry sector of the 브라질 보베스파 거래소 with ticker R1CL34. The last closing price for Royal Caribbean was R$740. Over the last year, Royal Caribbean shares have traded in a share price range of R$ 281.88 to R$ 897.81.

Royal Caribbean currently has 256,650,000 shares in issue. The market capitalisation of Royal Caribbean is R$189.92 billion. Royal Caribbean has a price to earnings ratio (PE ratio) of 36.61.

No news to show yet.

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	-9.75	-1.30260521042	748.5	766	723.43	164	739.56925519	DR
4	78.75	11.9318181818	660	897.81	660	97	735.87105177	DR
12	252.67	51.9811553654	486.08	897.81	470.31	92	613.40351116	DR
26	333.76	82.4119114052	404.99	897.81	392.4	82	540.2384121	DR
52	437.7	145.391131041	301.05	897.81	281.88	120	444.3982907	DR
156	518.75	235.795454545	220	897.81	84.58	306	193.58655141	DR
260	563.76	322.16698097	174.99	897.81	58.41	604	198.422497	DR

가장 활성
% 상승자
% 패자

기호	가격	볼륨
ATED3Atom Educacao E Editora S.A.	R$ 2.05 (39.46%)	267.1k
AGXY3Agrogalaxy Participacoes SA	R$ 0.50 (25.00%)	4.74M
DOTZ3Dotz S.A.	R$ 3.20 (18.96%)	68.4k
DASA11Diagnosticos da America S.A	R$ 1.08 (13.68%)	100
IFCM3Infracommerce Caxaas S.A.	R$ 0.09 (12.50%)	9.38M
COCE11Cia Energetica Ceara Coelce	R$ 0.39 (-35.00%)	11.7k
CRPG3TronoxPigmentos do Brasil S.A.	R$ 21.15 (-20.19%)	1.5k
QUAL3Qualicorp Consultoria e Corretora de Seguros S.A.	R$ 1.79 (-17.51%)	11.66M
EPAR3Embpar Participacoes S.A.	R$ 5.65 (-15.67%)	44.5k
AZEV3Azevedo Travassos Sa	R$ 1.07 (-13.71%)	1.29M
HAPV3Hapvida Participacoes Investimento SA	R$ 2.28 (-11.28%)	313.56M
COGN3CognaEducacao SA	R$ 1.09 (1.87%)	80.64M
BBDC4Bco Bradesco Sa	R$ 11.99 (0.756303%)	66.96M
ITSA4Itausa Investimentos Itau SA	R$ 9.04 (0.110742%)	52.07M
ITUB4Itau Unibanco Holding SA	R$ 31.88 (0.536108%)	40.11M

JMoneyHoops

JMoneyHoops 4 분 전

Verified profile! https://x.com/jmoney_hoops/status/1869205515588501520?s=46&t=EuLw-SVIgNfV5yGP5vc4tQ

dstock07734

dstock07734 4 분 전

KILLAZILLA

KILLAZILLA 5 분 전

DILUTION IS THE MAIN EYESORE....

WITHOUT SUBSTANTIAL REVENUE IT'S A POS DILUTION SCAM......

gitreal

gitreal 5 분 전

...where would our country be without folks daring to dream?

Pretty sad that you can't tell the difference between a grifting penny stock CEO and a legit startup entrepreneur. Or, even worse, you do know the difference and you are pretending, just to help promote the scam. I think i

flipper44

flipper44 6 분 전

Those people know we can still see them, right?

awesomed007

awesomed007 6 분 전

If it was selling on heavy volume, that would be a concern but very light volume during end of year portfolio rebalancing, tax harvesting happening, nah, just a few fools selling.

awesomed007

awesomed007 6 분 전

If it was selling on heavy volume, that would be a concern but very light volume during end of year portfolio rebalancing, tax harvesting happening, nah, just a few fools selling.

Eatatjoes

Eatatjoes 6 분 전

Paul Malec of Deer Park, NY

fuagf

fuagf 6 분 전

Yeps, yeps and yeps. Good ones.

NoMoDo

NoMoDo 6 분 전

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175527881 Meeting announced for TODAY

Better yet. Read this closely:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175530469
Ybyra agreed to purchase a company in France. Giving Dividends.

manibiotech

manibiotech 7 분 전

Well if you read the link you posted yourself , they are tracking in almost every other country on the planet . Please see the table . They are giving projected global scope of what is going on
I have no problem with you posting that link every hour of that pleases you

1vman

1vman 7 분 전

*****🚽UBQU🚽 Kevin Lamb is the typical OTC CEO , pocketing money while share holders lose amost all their investment

So much for forbes and da T0P 10 Health innovators wow!

🤔HUZZAH ENOUGH SAID !!!🤔

janice shell

janice shell 8 분 전

First of all, Syria is not a big oil producer. So it's a stupid idea. Trump has put it forward because he thinks everything should be his.

And because he's a moron.

https://investorshub.advfn.com/uimage/uploads/2024/12/17/oage%5BJPEG_image.jpeg

I must so

HappyAlways

HappyAlways 9 분 전

I am, as a Fannie shareholder, against any government action to dilute Fannie shareholders' interest. (1) The PSPA loan is no longer valid, given the NWS payments are way over the original 10% interest payments by $310B. (2) Any attempt to exercise the free warrant will be met with lawsuits, given t

TheDane

TheDane 9 분 전

Not only did it hold but it’s on the way back up.

OnTrack444

OnTrack444 9 분 전

Might see a dime after the RS!

If you think a 30B OS OTC stock is going to run from .0011 to .10 you're smoking something pretty whacky!! Find a low OS stock with catalysts in place and it's entirely possible but not this one my friend!!! GLTY

manibiotech

manibiotech 10 분 전

Interesting for sure but not conclusive which he repeat every day

But there are other things mentioned in that paragraph besides "Neuroscience" ( not Neuro-oncology). And there are other categories of vaccines in development even in neuroscience

FACT-MASTER

FACT-MASTER 11 분 전

Pivotal Study Design.

Through a meeting with the FDA, the Company obtained feedback on the potential registrational pathway following the Phase 1 ALLOHA trial. Based on this feedback, the Company believes that for a registrational trial: (1) the following proposed patient population i

arizona1

arizona1 12 분 전

Never trumpers are hilarious and brilliant too.

jimr1717

jimr1717 13 분 전

“ which now includes 17 issued U.S. patents and 84 pending”

It has taken them from $90,000 to $2 bucks in share price to get 17 of 101 patents.

There will be people that might need a million dollar share price to brake even by then.

This Fake it sham is

NoMoDo

NoMoDo 14 분 전

If we don't see a dime, I will be shocked.

Slyhunter

Slyhunter 14 분 전

I did Uber, when it was worth doing. Made, sometimes $300 a day at the b3e3ginning when they first started in my county, It was disastrous to not get out of the car and inspect the backseat to insure it was clean between fares, especially when driving dr8u8nks home at night. I don't see how Tesla is

nfrequent

nfrequent 14 분 전

Get ready. Phase One complete!!!
https://archive.fast-edgar.com/20241217/AP2Z522CZZ2R52V222JG2WY2CDQEZZ226L62/

XMaster2023

XMaster2023 14 분 전

Well now kinda sensitive. We can only talk about others tracking the approval one time because it doesn’t meet your short agenda? Funny how an American Society are tracking approval in the UK. They understand the approval will have a big impact on the gene therapy world. Your tacid comments will

Royal Caribbean

Dorsey Wright Developed ...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관